A Multi-part Study of ALG-000184 to Evaluate Safety, Tolerability, Pharmacokinetics and Drug-drug Interaction Potential After Single and Multiple Doses in Healthy Volunteers

PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 9, 2025

Primary Completion Date

July 7, 2025

Study Completion Date

July 7, 2025

Conditions

Healthy Volunteer

Interventions

DRUG

Carbamazepine

Commercially available supply.

DRUG

Itraconazole (Sporanox)

Commercially available supply.

DRUG

ALG-000184

Study Investigational Product

Trial Locations (1)

PPD Austin Research Unit, Austin